Whalegun
Home

Acadia Pharmaceuticals ACAD spent $180K on lobbying in Q3 2023 · Health Issues, Medicare

Trade details

Type
Lobbying report
Amount
$180,000
Quarter
Q3 2023
Stock
Acadia Pharmaceuticals ACAD
Client
Acadia Pharmaceuticals
Reported
23/10/18

Down 21.7% from last quarter

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/08/31~23/10/30

Acadia Pharmaceuticals's other lobbying reports